COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES

Aim. Direct immunogenicity comparison of adjuvants from various sources and with different mechanisms of action for inactivated influenza vaccines. Materials and methods. Groups of mice were immunized intramuscularly twice with an inactivated whole-virion influenza vaccine based on A/ California/07/...

Full description

Bibliographic Details
Main Authors: M. I Chernikova, O. S Kashirina, Yu. M Vasiliev
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2015-12-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.crie.ru/jour/article/view/14144
_version_ 1797782212103372800
author M. I Chernikova
O. S Kashirina
Yu. M Vasiliev
author_facet M. I Chernikova
O. S Kashirina
Yu. M Vasiliev
author_sort M. I Chernikova
collection DOAJ
description Aim. Direct immunogenicity comparison of adjuvants from various sources and with different mechanisms of action for inactivated influenza vaccines. Materials and methods. Groups of mice were immunized intramuscularly twice with an inactivated whole-virion influenza vaccine based on A/ California/07/2009 X-179A (H1N1) strain. The following adjuvants were added to the vaccine (10 in total): aluminium hydroxide, oligonucleotide CpG, complete Freund’s adjuvant, poly(lactide-co-glycolide) microparticles, monophosphoryl lipid A and polyoxidonium, as well as 2 adjuvants based on characterized chitosan substances with different physical/chemical properties and 2 experimental complex formulations (a multi-component adjuvant and an oil-in-water emulsion based on squalene and tocopherol). Immunogenicity was determined by HAI and MN (MDCK) sera antibodies. Results. Different adjuvants increased immunogenicity of the vaccine against the homologous strain in varying patterns. Experimental complex formulations were the most immunogenic (antibody titer increase reached 48 - 96 times compared with unadjuvanted vaccines). Chitosan based adjuvants showed high immunogenicity. Not all the adjuvants significantly increased immunogenicity, and in some cases even an immunogenicity decrease was noted with the addition of certain adjuvants. Conclusion. Research and development of chitosan based adjuvants with characterization and standardization issues addressed, as well as complex adjuvants, both multi-component and emulsion based, are the most promising approaches that could lead to next generation vaccines against influenza and other human and animal infectious diseases.
first_indexed 2024-03-13T00:07:49Z
format Article
id doaj.art-7b77a3b566c248709eb1a6ad4fb00bb4
institution Directory Open Access Journal
issn 0372-9311
2686-7613
language Russian
last_indexed 2024-03-13T00:07:49Z
publishDate 2015-12-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj.art-7b77a3b566c248709eb1a6ad4fb00bb42023-07-12T20:21:14ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132015-12-0192663712569COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINESM. I Chernikova0O. S Kashirina1Yu. M Vasiliev2Mechnikov Research Institute of Vaccines and SeraMechnikov Research Institute of Vaccines and SeraMechnikov Research Institute of Vaccines and SeraAim. Direct immunogenicity comparison of adjuvants from various sources and with different mechanisms of action for inactivated influenza vaccines. Materials and methods. Groups of mice were immunized intramuscularly twice with an inactivated whole-virion influenza vaccine based on A/ California/07/2009 X-179A (H1N1) strain. The following adjuvants were added to the vaccine (10 in total): aluminium hydroxide, oligonucleotide CpG, complete Freund’s adjuvant, poly(lactide-co-glycolide) microparticles, monophosphoryl lipid A and polyoxidonium, as well as 2 adjuvants based on characterized chitosan substances with different physical/chemical properties and 2 experimental complex formulations (a multi-component adjuvant and an oil-in-water emulsion based on squalene and tocopherol). Immunogenicity was determined by HAI and MN (MDCK) sera antibodies. Results. Different adjuvants increased immunogenicity of the vaccine against the homologous strain in varying patterns. Experimental complex formulations were the most immunogenic (antibody titer increase reached 48 - 96 times compared with unadjuvanted vaccines). Chitosan based adjuvants showed high immunogenicity. Not all the adjuvants significantly increased immunogenicity, and in some cases even an immunogenicity decrease was noted with the addition of certain adjuvants. Conclusion. Research and development of chitosan based adjuvants with characterization and standardization issues addressed, as well as complex adjuvants, both multi-component and emulsion based, are the most promising approaches that could lead to next generation vaccines against influenza and other human and animal infectious diseases.https://microbiol.crie.ru/jour/article/view/14144influenzainactivated vaccinesimmunogenicityadjuvantsimmunoadjuvantschitosan
spellingShingle M. I Chernikova
O. S Kashirina
Yu. M Vasiliev
COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
Журнал микробиологии, эпидемиологии и иммунобиологии
influenza
inactivated vaccines
immunogenicity
adjuvants
immunoadjuvants
chitosan
title COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
title_full COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
title_fullStr COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
title_full_unstemmed COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
title_short COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
title_sort comparative immunogenicity studies of adjuvants from various sources and with different mechanisms of action for inactivated influenza vaccines
topic influenza
inactivated vaccines
immunogenicity
adjuvants
immunoadjuvants
chitosan
url https://microbiol.crie.ru/jour/article/view/14144
work_keys_str_mv AT michernikova comparativeimmunogenicitystudiesofadjuvantsfromvarioussourcesandwithdifferentmechanismsofactionforinactivatedinfluenzavaccines
AT oskashirina comparativeimmunogenicitystudiesofadjuvantsfromvarioussourcesandwithdifferentmechanismsofactionforinactivatedinfluenzavaccines
AT yumvasiliev comparativeimmunogenicitystudiesofadjuvantsfromvarioussourcesandwithdifferentmechanismsofactionforinactivatedinfluenzavaccines